Target
Receptor-interacting serine/threonine-protein kinase 1
Ligand
BDBM50513013
Substrate
n/a
Meas. Tech.
ChEMBL_1851532 (CHEMBL4352156)
IC50
2.0±n/a nM
Citation
 Harris, PAFaucher, NGeorge, NEidam, PMKing, BWWhite, GVAnderson, NABandyopadhyay, DBeal, AMBeneton, VBerger, SBCampobasso, NCampos, SCapriotti, CACox, JADaugan, ADonche, FFouchet, MHFinger, JNGeddes, BGough, PJGrondin, PHoffman, BLHoffman, SJHutchinson, SEJeong, JUJigorel, ELamoureux, PLeister, LKLich, JDMahajan, MKMeslamani, JMosley, JENagilla, RNassau, PMNg, SLOuellette, MTPasikanti, KKPotvain, FReilly, MARivera, EJSautet, SSchaeffer, MCSehon, CASun, HThorpe, JHTotoritis, RDWard, PWellaway, NWisnoski, DDWoolven, JMBertin, JMarquis, RW Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase. J Med Chem 62:5096-5110 (2019) [PubMed]  Article 
Target
Name:
Receptor-interacting serine/threonine-protein kinase 1
Synonyms:
Cell death protein RIP | RIP | RIP-1 | RIP1 | RIPK1 | RIPK1_HUMAN | Receptor-interacting protein 1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
75926.99
Organism:
Homo sapiens (Human)
Description:
Q13546
Residue:
671
Sequence:
MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN
  
Inhibitor
Name:
BDBM50513013
Synonyms:
CHEMBL4450890
Type:
Small organic molecule
Emp. Form.:
C20H18F2N6O
Mol. Mass.:
396.3933
SMILES:
Fc1cc(F)cc(c1)[C@@H]1CC=NN1C(=O)C1CCN(CC1)c1cnc(cn1)C#N |r,c:11|
Structure:
Search PDB for entries with ligand similarity: